Cato Research

Welcome to Cato Research - a full-service contract research and development organization with international resources dedicated to helping pharmaceutical and biotechnology companies efficiently and expeditiously navigate the regulatory approval process in order to bring new drugs, biologics, and medical devices to the people who need them.

» Company Overview | Contact Us

Press Releases

  • February 23, 2009 - Cordex Pharma Announces Strategic Master Services Equity Agreement with Cato BioVentures

  • February 2, 2009 - Cancer Advances Acquires the Technology and Intellectual Property for a Suite of Products that Enhance the Immune System in Treatment of Gastric, Pancreatic and Colorectal Cancers

  • September 22, 2008 - Transdel Enrolls First Patient for Ketotransdel(TM) Phase 3 Clinical Trial with Cato Research

  • More...
Investigator Registry Upcoming Events
Event Registration
Home | About | Services | Sponsor Benefits | Therapeutic Experience | Careers | News Center | Contact | Links
© 2009 Cato Research. All rights reserved. | Web design by Fensons